Shandong Jincheng Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Shandong Jincheng Pharmaceutical Group has a total shareholder equity of CN¥3.8B and total debt of CN¥636.3M, which brings its debt-to-equity ratio to 16.7%. Its total assets and total liabilities are CN¥5.9B and CN¥2.1B respectively. Shandong Jincheng Pharmaceutical Group's EBIT is CN¥257.4M making its interest coverage ratio 28.4. It has cash and short-term investments of CN¥1.1B.
Key information
16.7%
Debt to equity ratio
CN¥636.31m
Debt
| Interest coverage ratio | 28.4x |
| Cash | CN¥1.05b |
| Equity | CN¥3.82b |
| Total liabilities | CN¥2.08b |
| Total assets | CN¥5.90b |
Recent financial health updates
Recent updates
Shandong Jincheng Pharmaceutical Group's (SZSE:300233) Problems Go Beyond Weak Profit
Apr 04
Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Climb 29% But Its Business Is Yet to Catch Up
Mar 04Shandong Jincheng Pharmaceutical Group (SZSE:300233) Seems To Use Debt Quite Sensibly
Mar 02Financial Position Analysis
Short Term Liabilities: 300233's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 300233's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥571.0M).
Debt to Equity History and Analysis
Debt Level: 300233 has more cash than its total debt.
Reducing Debt: 300233's debt to equity ratio has increased from 11.8% to 16.7% over the past 5 years.
Debt Coverage: 300233's debt is well covered by operating cash flow (106.7%).
Interest Coverage: 300233's interest payments on its debt are well covered by EBIT (28.4x coverage).